X @The Wall Street Journal
Novo Nordisk(US:NVO) The Wall Street Journal·2025-12-23 14:12The FDA approved the first GLP-1 weight-loss pill—a tablet formulation of Novo Nordisk’s Ozempic and Wegovy—ushering in a new era of the obesity-drugs revolution that is expected to broaden their use.Read more: 🔗 https://t.co/i6eRDzroe1 https://t.co/FdtAJvIjtA ...